GKIM
ELV icon

GW&K Investment Management’s Elevance Health ELV Stock Holding History

GW&K Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77K Buy
199
+34
+21% +$12.6K ﹤0.01% 516
2026
Q1 		$48K Sell
165
-27
-14% -$8.87K ﹤0.01% 567
2025
Q4 		$67K Buy
192
+7
+4% +$2.37K ﹤0.01% 508
2025
Q3 		$60K Sell
185
-32
-15% -$9.95K ﹤0.01% 505
2025
Q2 		$84K Buy
217
+30
+16% +$12.1K ﹤0.01% 441
2025
Q1 		$81K Buy
187
+20
+12% +$8.03K ﹤0.01% 426
2024
Q4 		$62K Buy
167
+3
+2% +$1.25K ﹤0.01% 444
2024
Q3 		$85K Buy
164
+7
+4% +$3.74K ﹤0.01% 407
2024
Q2 		$85K Buy
157
+27
+21% +$14.3K ﹤0.01% 397
2024
Q1 		$67K Buy
130
+60
+86% +$29.8K ﹤0.01% 402
2023
Q4 		$33K Buy
70
+4
+6% +$1.85K ﹤0.01% 447
2023
Q3 		$29K Sell
66
-4
-6% -$1.81K ﹤0.01% 445
2023
Q2 		$31K Buy
+70
New +$32.3K ﹤0.01% 421
2022
Q3 		– Sell
-24
Closed -$12K – 533
2022
Q2 		$12K Buy
24
+8
+50% +$3.96K ﹤0.01% 457
2022
Q1 		$8K Buy
+16
New +$7.31K ﹤0.01% 450

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GW&K Investment Management's ELV Position: Q2 2026 in Review

GW&K Investment Management increased its Elevance Health (ELV) stake by 21% in Q2 2026, buying an estimated $12.6K and bringing the position to 199 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #516.

GW&K Investment Management first reported a position in ELV in Q1 2022 and has held it in 15 quarters since. The position peaked at $85K in Q3 2024. 1,611 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • GW&K Investment Management held 199 shares of Elevance Health worth $77K as of Q2 2026.
  • GW&K Investment Management bought 34 Elevance Health shares in Q2 2026, an estimated $12.6K.
  • Elevance Health made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #516 holding.
  • GW&K Investment Management first reported a position in Elevance Health in Q1 2022 and has held it in 15 quarters since.
  • GW&K Investment Management's Elevance Health position peaked at $85K in Q3 2024.
  • 1,611 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.